I also very much appreciate the article and the writer Micheal Rogucki is no slouch when it comes to innovation in his own right after reading s short expose of his own achievements at end of the article. Geez! After reading it I am of a higher understanding of the magnitude of what p-ESR is and it’s perfect advantage when compared to current technologies plus a room temperature.As the reader it is pretty clear that this chip is ground breaking in its own right and has me thinking about the reality and possible ramifications of Archers’ and EPFL’s work. Yes! I am also thinking near term price catalyst that hasn’t burst purely for the reason that most of us don’t have the foggiest and I am first to admit I’m a long way behind Geeris. Thank you for your fabulous contributions Finally, the article clearly mentioned an Open Access Journal for the purpose of sharing with the Scientific community so perhaps we will receive high level endorsements via this avenue? A little bit in a Spin here and have picked up additional shares in recent weeks.
- Forums
- ASX - By Stock
- $3 WATCH OUT !!!
I also very much appreciate the article and the writer Micheal...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AXE (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $80.27M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 30.5¢ | $121.0K | 379.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 29670 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 54999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29670 | 0.310 |
3 | 21500 | 0.305 |
4 | 204970 | 0.300 |
6 | 99398 | 0.295 |
5 | 38817 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 54999 | 1 |
0.320 | 44730 | 1 |
0.325 | 6000 | 2 |
0.330 | 84892 | 1 |
0.335 | 24549 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online